Circio 1H 2025 presentation: circVec technology shows 10-40x advantage in gene therapy
Post Content
Business & Finance
Stay informed with expert takes on business strategy, investing, entrepreneurship, and global markets. CurioAtlas brings you articles that guide smarter decisions in finance and business growth.
EQVA ASA Q2 2025 presentation: 47% revenue growth fueled by acquisition strategy
Post Content
Lytix Biopharma Q2 2025 slides: advancing cancer therapy toward Phase III with improved financials
Post Content
Elliptic Labs Q2 2025 slides: Revenue dips, major contracts secured for growth
Post Content
Cavendish Hydrogen Q2 2025 slides: Record dispensing volumes offset by revenue decline
Post Content
Nekkar Q2 2025 slides: Revenue drops amid cost overruns, order backlog remains strong
Post Content
China AI major Cambricon shares hit record high as Nvidia flags more H20 doubts
Post Content
India’s Nifty 50 hits 2-week low after steep US tariffs take effect
Post Content
UBS downgrades Globe Telecom stock to Neutral on regulatory concerns
Post Content
Morning Bid: Nvidia kills the buzz as profit merely awesome, not legendary
Post Content